Effects of different concentrations of Platelet-rich Plasma and Platelet-Poor Plasma on vitality and differentiation of autologous Adipose tissue-derived stem cells
Restricted accessResearch articleFirst published online May 5, 2017
Effects of different concentrations of Platelet-rich Plasma and Platelet-Poor Plasma on vitality and differentiation of autologous Adipose tissue-derived stem cells
BACKGROUND: Autologous fat grafts and adipose-derived stem cells (ASCs) can be used to treat soft tissue defects. However, the results are inconsistent and sometimes comprise tissue resorption and necrosis. This might be due to insufficient vascularization. Platelet-rich plasma (PRP) is a source of concentrated autologous platelets. The growth factors and cytokines released by platelets can facilitate angiogenesis. The simultaneous use of PRP might improve the regeneration potential of fat grafts. The optimal ratio has yet to be elucidated. A byproduct of PRP preparation is platelet-poor plasma (PPP).
OBJECTIVE: In this study we investigated the influence of different concentrations of PRP on the vitality and differentiation of ASCs.
METHODS: We processed whole blood with the Arthrex Angel centrifuge and isolated ASCs from the same donor. We tested the effects of different PRP and PPP concentrations on the vitality using resazurin assays and the differentiation of ASCs using oil-red staining.
RESULTS: Both cell vitality and adipogenic differentiation increase to a concentration of 10% to 20% PRP. With a PRP concentration of 30% cell vitality and differentiation decrease.
CONCLUSIONS: Both PRP and PPP can be used to expand ASCs without xenogeneic additives in cell culture. A PRP concentration above 20% has inhibitory effects.
GuerrerosantosJ., Long-term outcome of autologous fat transplantation in aesthetic facial recontouring: Sixteen years of experience with 1936 cases, Clin Plast Surg27(4) (2000), 515–543.
3.
KaufmanM.R., BradleyJ.P., DickinsonB., HellerJ.B., WassonK., O’HaraC., HuangC., GabbayJ., GhadjarK. and MillerT.A., Autologous fat transfer national consensus survey: Trends in techniques for harvest, preparation, and application, and perception of short- and long-term results, Plast Reconstr Surg119(1) (2007), 323–331.
4.
LiaoH.T., MarraK.G. and RubinJ.P., Application of platelet-rich plasma and platelet-rich fibrin in fat grafting: Basic science and literature review, Tissue Eng Part B Rev20(4) (2014), 267–276.
5.
SchremlS., BabilasP., FruthS., OrsóE., SchmitzG., MuellerM.B., NerlichM. and PrantlL., Harvesting human adipose tissue-derived adult stem cells: Resection versus liposuction, Cytotherapy11(7) (2009), 947–957.
6.
AustL., DevlinB., FosterS.J., HalvorsenY.D., HicokK., du LaneyT., et al., Yield of human adipose-derived adult stem cells from liposuction aspirates, Cytotherapy6 (2004), 7–14.
7.
ZukP.A., ZhuM., MizunoH., HuangJ., FutrellJ.W., KatzA.J., et al., Multilineage cells from human adipose tissue: Implications for cell-based therapies, Tissue Eng7 (2001), 211–228.
8.
DominiciM., Le BlancK., MuellerI., Slaper-CortenbachI., MariniF., KrauseD., DeansR., KeatingA., ProckopE. and HorwitzE., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy8(4) (2006), 315–317.
9.
YoshimuraK., SatoK., AoiN., KuritaM., HirohiT. and HariiK., Cell-assisted lipotransfer for cosmetic breast augmentation: Supportive use of adipose-derived stem/stromal cells, Aesthetic Plast Surg32(1) (2008), 48–55; discussion 56-7.
10.
SterodimasA., de FariaJ., NicarettaB., PapadopoulosO., PapalambrosE. and IllouzY.G., Cell-assisted lipotransfer, Aesthet Surg J30(1) (2010), 78–81.
11.
RigottiG., MarchiA., GalièM., BaroniG., BenatiD., KramperaM., PasiniA. and SbarbatiA., Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose-derived adult stem cells, Plast Reconstr Surg119(5) (2007), 1409–1422.
12.
StoltzJ.F., BensoussanD., De IslaN., ZhangL., HanZ., MagdalouJ., HuselsteinC., YeJ.S., LiN., DecotV. and ReppelL., Stem cells and vascular regenerative medicine, Clin Hemorheol Microcirc (2016). doi: 10.3233/CH-168036.
13.
SchallmoserK., BartmannC., RohdeE., ReinischA., KashoferK., StadelmeyerE., DrexlerC., LanzerG., LinkeschW. and StrunkD., Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells, Transfusion47(8) (2007), 1436–1446.
14.
ChimentiI., GaetaniR., ForteE., AngeliniF., De FalcoE., ZoccaiG.B., MessinaE., FratiG. and GiacomelloA., Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture, J Cell Mol Med18(4) (2014), 624–634.
15.
TavakolinejadS., KhosraviM., MashkaniB., Ebrahimzadeh BideskanA., Sanjar MossaviN., ParizadehM.R. and Hamidi AlamdariD., The effect of human platelet-rich plasma on adipose-derived stem cell proliferation and osteogenic differentiation, Iran Biomed J18(3) (2014), 151–157.
16.
MarlovitsS., MousaviM., GäblerC., ErdösJ. and VécseiV., A new simplified technique for producing platelet-rich plasma: A short technical note, Eur Spine J13(Suppl 1) (2004), S102–S106.
17.
EppleyB.L., PietrzakW.S. and BlantonM., Platelet-rich plasma: A review of biology and applications in plastic surgery, Plast Reconstr Surg118(6) (2006), 147e–159e.
18.
MarxR.E., Platelet-rich plasma: Evidence to support its use, J Oral Maxillofac Surg62(4) (2004), 489–496.
19.
FosterT.E., PuskasB.L., MandelbaumB.R., GerhardtM.B. and RodeoS.A., Platelet-rich plasma: From basic science to clinical applications, Am J Sports Med37(11) (2009), 2259–2272.
KimE.S., KimJ.J. and ParkE.J., Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material, J Adv Prosthodont2(1) (2010), 7–13.
22.
CervelliV., ScioliM.G., GentileP., DoldoE., BonannoE., SpagnoliL.G. and OrlandiA., Platelet-rich plasma greatly potentiates insulin-induced adipogenic differentiation of human adipose-derived stem cells through a serine/threonine kinase Akt-dependent mechanism and promotes clinical fat graft maintenance, Stem Cells Transl Med1(3) (2012), 206–220.
23.
GentileP., Di PasqualiC., BocchiniI., FlorisM., EleonoraT., FiaschettiV., FlorisR. and CervelliV., Breast reconstruction with autologous fat graft mixed with platelet-rich plasma, Surg Innov20(4) (2013), 370–376.
24.
HaubnerF., MuschterD., SchusterN., PohlF., AhrensN., PrantlL. and GassnerH.G., Platelet-rich plasma stimulates dermal microvascular endothelial cells and adipose derived stem cells after external radiation, Clin Hemorheol Microcirc61(2) (2015), 279–290.
25.
CavalloC., FilardoG., MarianiE., KonE., MarcacciM., Pereira RuizM.T., FacchiniA. and GrigoloB., Comparison of platelet-rich plasma formulations for cartilage healing: An in vitro study, J Bone Joint Surg Am96(5) (2014), 423–429.
26.
RennT.Y., KaoY.H., WangC.C. and BurnoufT., Anti-inflammatory effects of platelet biomaterials in a macrophage cellular model, Vox Sang109(2) (2015), 138–147.
27.
DeLongJ.M., RussellR.P. and MazzoccaA.D., Platelet-rich plasma: The PAW classification system, Arthroscopy28(7) (2012), 998–1009. doi: 10.1016/j.arthro.2012.04.148.
28.
OhJ.H., KimW., ParkK.U. and RohY.H., Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations, Am J Sports Med43(12) (2015), 3062–3070.
29.
DenapoliP.M., StilhanoR.S., InghamS.J., HanS.W. and AbdallaR.J., Platelet-Rich Plasma in a Murine Model: Leukocytes, Growth Factors, Flt-1, and Muscle Healing, Am J Sports Med44(8) (2016), 1962–1971.
30.
ChajryN., MartinP.M., PagesG., CochetC., AfdelK. and BerthoisY., Relationship between the MAP kinase activity and the dual effect of EGF on A431 cell proliferation, Biochem Biophys Res Commun203(2) (1994), 984–990.
31.
SilvyM., MartinP.M., ChajryN. and BerthoisY., Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: Evidence for a signal transduction pathway that can bypass Raf-1 activation, Endocrinology139(5) (1998), 2382–2391.
32.
VogelJ.P., SzalayK., GeigerF., KramerM., RichterW. and KastenP., Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics, Platelets17(7) (2006), 462–469.
33.
AmableP.R., TeixeiraM.V., CariasR.B., GranjeiroJ.M. and BorojevicR., Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media, PLoS One9(8) (2014), e104662.
34.
WangW. and SealeP., Control of brown and beige fat development, Nat Rev Mol Cell Biol17(11) (2016), 691–702.
35.
YadavH. and RaneS.G., TGF-β/Smad3 signaling regulates brown. Adipocyte induction in white adipose tissue, Front Endocrinol (Lausanne)14(3) (2012), 35.
36.
NamD., GuoB., ChatterjeeS., ChenM.H., NelsonD., YechoorV.K. and MaK., The adipocyte clock controls brown adipogenesis through the TGF-β and BMP signaling pathways, J Cell Sci128(9) (2015), 1835–1847.
37.
GarcíaB. and ObregónM.J., Growth factor regulation of uncoupling protein-1 mRNA expression in brown adipocytes, Am J Physiol Cell Physiol282(1) (2002), C105–C112.
38.
CypessA.M., ZhangH., SchulzT.J., HuangT.L., EspinozaD.O., KristiansenK., UntermanT.G. and TsengY.H., Insulin/IGF-I regulation of necdin and brown adipocyte differentiation via CREB- and FoxO1-associated pathways, Endocrinology152(10) (2011), 3680–3689.
39.
DuringM.J., LiuX., HuangW., MageeD., SlaterA., McMurphyT., WangC. and CaoL., Adipose VEGF links the white-to-brown fat switch with environmental, genetic, and pharmacological stimuli in male mice, Endocrinology156(6) (2015), 2059–2073.
40.
JoD.H., ParkS.W., ChoC.S., PownerM.B., KimJ.H., FruttigerM. and KimJ.H., Intravitreally injected anti-vegf antibody reduces brown fat in neonatal mice, PLoS One10(7) (2015), e0134308.
41.
LiuJ., DivouxA., SunJ., ZhangJ., ClémentK., GlickmanJ.N., SukhovaG.K., WoltersP.J., DuJ., GorgunC.Z., DoriaA., LibbyP., BlumbergR.S., KahnB.B., HotamisligilG.S. and ShiG.P., Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice, Nat Med15(8) (2009), 940–945.
42.
MarzettiE., D’AngeloE., SaveraG., LeeuwenburghC. and CalvaniR., Integrated control of brown adipose tissue, Heart Metab69 (2016), 9–14.
43.
El-SharkawyH., KantarciA., DeadyJ., HasturkH., LiuH., AlshahatM. and Van DykeT.E., Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties, J Periodontol78(4) (2007), 661–669.
